Healthcare provider profile · identity verified

Deepak Cuddapah, MD

Family Practice · GOLDSBORO, NC · NPI 1801994819

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	330	99
Amlodipine Besylate	Amlodipine Besylate	316	86
Levothyroxine Sodium	Levothyroxine Sodium	309	81
Atorvastatin Calcium	Atorvastatin Calcium	240	76
Hydrochlorothiazide	Hydrochlorothiazide	236	65
Metformin Hcl	Metformin Hcl	234	65
Omeprazole	Omeprazole	225	66
Losartan Potassium	Losartan Potassium	189	55
Tramadol Hcl	Tramadol Hcl	141	60
Gabapentin	Gabapentin	140	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	129	53
Meloxicam	Meloxicam	124	29
Prednisone	Prednisone	116	84
Metoprolol Succinate	Metoprolol Succinate	112	29
Pantoprazole Sodium	Pantoprazole Sodium	96	27
Furosemide	Furosemide	93	27
Rosuvastatin Calcium	Rosuvastatin Calcium	93	29
Trazodone Hcl	Trazodone Hcl	90	29
Alprazolam	Alprazolam	79	21
Escitalopram Oxalate	Escitalopram Oxalate	79	16
Albuterol Sulfate Hfa	Albuterol Sulfate	78	38
Simvastatin	Simvastatin	78	24
Allopurinol	Allopurinol	76	23
Metoprolol Tartrate	Metoprolol Tartrate	76	25
Amitriptyline Hcl	Amitriptyline Hcl	74	22
Pravastatin Sodium	Pravastatin Sodium	72	23
Alendronate Sodium	Alendronate Sodium	70	15
Jardiance	Empagliflozin	64	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	21
Tamsulosin Hcl	Tamsulosin Hcl	64	20
Duloxetine Hcl	Duloxetine Hcl	62	20
Clopidogrel	Clopidogrel Bisulfate	60	19
Eliquis	Apixaban	56	14
Buspirone Hcl	Buspirone Hcl	54	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	11
Pioglitazone Hcl	Pioglitazone Hcl	51	13
Donepezil Hcl	Donepezil Hcl	50	12
Potassium Chloride	Potassium Chloride	49	14
Doxepin Hcl	Doxepin Hcl	46	suppressed
Glipizide Er	Glipizide	46	13
Montelukast Sodium	Montelukast Sodium	46	14
Clonidine Hcl	Clonidine Hcl	45	11
Fluticasone Propionate	Fluticasone Propionate	45	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	13
Metformin Hcl Er	Metformin Hcl	44	15
Spironolactone	Spironolactone	44	14
Carvedilol	Carvedilol	43	14
Glimepiride	Glimepiride	43	suppressed
Sertraline Hcl	Sertraline Hcl	42	15
Glipizide	Glipizide	41	12
Lorazepam	Lorazepam	41	12
Ozempic	Semaglutide	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	17
Finasteride	Finasteride	38	suppressed
Tresiba Flextouch U-100	Insulin Degludec	38	suppressed
Azithromycin	Azithromycin	35	32
Famotidine	Famotidine	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Januvia	Sitagliptin Phosphate	34	12
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	25
Propranolol Hcl	Propranolol Hcl	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Atenolol	Atenolol	26	suppressed
Colchicine	Colchicine	26	11
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Valsartan	Valsartan	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Sucralfate	Sucralfate	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Victoza 3-Pak	Liraglutide	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Fluocinonide	Fluocinonide	23	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Linzess	Linaclotide	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Temazepam	Temazepam	15	suppressed
Cephalexin	Cephalexin	14	14
Farxiga	Dapagliflozin Propanediol	14	suppressed
Indomethacin	Indomethacin	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Mitigare	Colchicine	13	suppressed
Naproxen	Naproxen	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluconazole	Fluconazole	12	11
Gemfibrozil	Gemfibrozil	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Propylthiouracil	Propylthiouracil	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Digoxin	Digoxin	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nystatin	Nystatin	11	suppressed
Ramipril	Ramipril	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error